Skip to main content
Loading market data...

Compare ETFs

Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.

Two to four symbols separated by commas. ASX funds end in .AX, for example A200.AX.
General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Side by side

Comparison of HELX, IVV
Measure HELXFranklin Genomic Advancements ETF IVViShares Core S&P 500 ETF
MarketUSCboe BZXUSNYSE Arca
IssuerFranklin TempletoniShares
Asset classEquity · USEquity · US
Expense ratio0.50%Expense ratio, filed 28 Jul 20250.03%Expense ratio, filed 22 Jul 2025
Net assets$27.9MAs of 30 Jun 2026 $888.1BAs of 30 Jun 2026
Holdings63As of 30 Jun 2026 508As of 30 Jun 2026
12-month distribution yield0.34%1.09%
DistributionsIrregular$0.1430 in 12 months Quarterly$8.3970 in 12 months
Last price$41.6620 Oct 2026, 14:15 UTC$772.3520 Oct 2026, 20:00 UTC

Holdings overlap

Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.

Weighted holdings overlap between each pair of funds
FundHELXIVV
HELX Same fund 2.8%
IVV 2.8% Same fund

HELX and IVV

Weighted overlap
2.8%
Of each fund's net assets
Holdings in common
11
61 in HELX, 504 in IVV
HELX holdings also in IVV
18.0% by count
14.9% of HELX by weight
IVV holdings also in HELX
2.2% by count
2.8% of IVV by weight

Common holdings matched: 11 by ISIN, 0 by CUSIP and 0 by issuer name. Holdings as of 30 Jun 2026 (HELX) and 30 Jun 2026 (IVV).

Largest positions held by both HELX and IVV
HoldingWeight in HELXWeight in IVVOverlapMatched by
ELI LILLY & COMPANYELI LILLY & COMPANY COM US5324571083 2.95% 1.47% 1.47% ISIN
THERMO FISHER SCIENTIFIC INCTHERMO FISHER SCIENTIFIC INC COM US8835561023 0.76% 0.29% 0.29% ISIN
VERTEX PHARMACEUTICALS INCVERTEX PHARMACEUTICALS INC COM US92532F1003 2.75% 0.20% 0.20% ISIN
DANAHER CORPDANAHER CORP COM US2358511028 0.57% 0.19% 0.19% ISIN
BRISTOL-MYERS SQUIBB COMPANYBRISTOL-MYERS SQUIBB COMPANY COM US1101221083 0.25% 0.18% 0.18% ISIN
CADENCE DESIGN SYSTEMS INCCADENCE DESIGN SYSTEMS INC COM US1273871087 0.97% 0.16% 0.16% ISIN
REGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INC COM US75886F1075 1.80% 0.10% 0.10% ISIN
CORTEVA INCCORTEVA INC COM US22052L1044 2.25% 0.09% 0.09% ISIN
AGILENT TECHNOLOGIES INCAGILENT TECHNOLOGIES INC COM US00846U1016 0.58% 0.06% 0.06% ISIN
IQVIA HOLDINGS INCIQVIA HOLDINGS INC COM US46266C1053 0.75% 0.05% 0.05% ISIN
How overlap is measured

Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.

Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.

Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.

The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.

Currency exposure

Weight of holdings denominated in each currency
CurrencyHELXIVV
US dollar (USD) 93.6% 100.1%
South Korean won (KRW) 2.6% Below the top 12 or none
Euro (EUR) 2.5% Below the top 12 or none
IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme